دورية أكاديمية

Alliance A222001: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy.

التفاصيل البيبلوغرافية
العنوان: Alliance A222001: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy.
المؤلفون: Stish, Brad J., Mazza, Gina L., Nauseef, Jones T., Humeniuk, Michael Sandon, Smith, Thomas J., Tofthagen, Cindy, Diaz Pardo, Dayssy Alexandra, Chay, Christopher H., Huang, Andrew Jonathan, Naha, Kushal, Tagawa, Scott T., Chow, Selina Lai-ming, Adams-Campbell, Lucile L., Novotny, Paul J., Loprinzi, Charles L.
المصدر: Journal of Clinical Oncology; 2024 Supplement 17, Vol. 42, pLBA12004-LBA12004, 83p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2024.42.17_suppl.LBA12004